|
Description:
|
|
Tweet
mRNA vaccines have recently been in the news as an exciting potential preventative of SARS-CoV2. The technology seems new, but has roots in the 1990’s and a long history of maturation, plagued by technical barriers and skepticism. However, the efficacy demonstrated in clinical trials is promising, and suggests that mRNA-based strategies may have a prominent role as vaccines and therapeutics against some of our most insidious diseases.
Resources for this podcast:
Hilleman 1994 – a conceptual review of the potential for mRNA vaccines, predicing many of its challenges.
Kariko et al, 2005 – This paper contains information on how mRNA may be modified to limit its inherent antigenic activity.
Schlake et al., 2012 – A very good primer to the history and theory of mRNA vaccine development. |